Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The companys products include sequencing platforms that are based on its SBS technology are designed to meet the various demands of a range of sequencing applications; and array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of array-based genetic analysis products. It also offers various sample preparation and sequencing kits to simplify workflows and accelerate analysis. In addition, the company provides genotyping and whole genome sequencing services. It serves genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company sells its products directly, as well as through distributors. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Commit To Purchase Illumina At $130, Earn 7.7% Using Options31 Mar 2015, 11:10 amCommit To Purchase Illumina At $130, Earn 7.7% Using Options
The Zacks Analyst Blog Highlights: Horizon Pharma, NewLink Genetic and llumina - Press Releases27 Mar 2015, 7:30 amThe Zacks Analyst Blog Highlights: Horizon Pharma, NewLink Genetic and llumina
The Zacks Analyst Blog Highlights: Methode Electronics, Newmont Mining, Valero Energy and Quest Diagnostics - Press ...27 Mar 2015, 7:30 amThe Zacks Analyst Blog Highlights: Methode Electronics, Newmont Mining, Valero Energy and Quest Diagnostics
MedTech M&As Continue Regardless of Tax Scenarios - Industry Outlook26 Mar 2015, 2:28 pmMedTech M&As Continue Regardless of Tax Scenarios - Industry Outlook
3 Biotech Stocks Bucking Short Interest Trends26 Mar 2015, 1:35 pmBy and large, the short interest moves in the leading biotechs and emerging pharmaceuticals were mild between the February 27 and March 13 settlement dates. However, Celgene Corporation (NASDAQ: CELG ), ...
The March Madness 'Sweet 16' of Stocks - Analyst Blog26 Mar 2015, 12:55 pmFrom four top industry brackets, we can help fill out winners for your portfolio.
The Zacks Analyst Blog Highlights: Natus Medical, Mead Johnson Nutrition, Amedisys, Quest Diagnostics and Illumina ...23 Mar 2015, 7:30 amThe Zacks Analyst Blog Highlights: Natus Medical, Mead Johnson Nutrition, Amedisys, Quest Diagnostics and Illumina
Illumina (ILMN) Files NIPT Patent Infringement Suit in UK - Analyst Blog20 Mar 2015, 4:05 pmGlobal leader in sequencing and array-based technologies, Illumina, Inc. (ILMN), along with its wholly-owned subsidiary, Verinata Health Inc., has lodged a patent infringement suit against Premaitha Health.
Is Illumina (ILMN) Worth Adding to Your Portfolio Now? - Analyst Blog13 Mar 2015, 2:00 pmOn Mar 12, 2015, we issued an updated research report on Illumina Inc. (ILMN).
Illumina Partners Merck KGaA to Develop Precision Medicine - Analyst Blog12 Mar 2015, 4:11 pmIllumina Inc. (ILMN) recently formed an alliance with Merck Serono, the biopharmaceuticals business of Germany's Merck KGaA.